Clinical protocol for a randomized, double-blind, placebo-controlled study of the efficacy and safety of celecoxib (SC-58635) in the prevention of colorectal sporadic adenomatous polyps.

Trial Profile

Clinical protocol for a randomized, double-blind, placebo-controlled study of the efficacy and safety of celecoxib (SC-58635) in the prevention of colorectal sporadic adenomatous polyps.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2011

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Colorectal cancer; Intestinal polyps; Polyps; Sporadic adenomas
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms PRESAP
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Jun 2008 Five-year results from 1043 patients published as an abstract in Gastroenterology.
    • 20 Dec 2007 The completion date for this trial is now 1 May 2007.
    • 04 May 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top